Vagiannis, Dimitrios; Budagaga, Youssif; Morell, Anselm; Zhang, Yu; Novotna, Eva; Skarka, Adam; Kammerer, Sarah; Kupper, Jan-Heiner; Hanke, Ivo; Rozkos, Tomas; Hofman, Jakub
(MDPI, 2021)
Tepotinib is a novel tyrosine kinase inhibitor recently approved for the treatment of non-small cell lung cancer (NSCLC). In this study, we evaluated the tepotinib's potential to perpetrate pharmacokinetic drug interactions ...